α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons

Journal of Cell Science

Volumn 128, Issue 13, 2015, Pages 2231-2243

  Zaltieri, Michela ^a   Grigoletto, Jessica ^a   Longhena, Francesca ^a   Navarria, Laura ^a   Favero, Gaia ^a   Castrezzati, Stefania ^a   Colivicchi, Maria Alessandra ^b   Corte, Laura Della ^b   Rezzani, Rita ^a   Pizzi, Marina ^a,f   Benfenati, Fabio ^c,d   Spillantini, Maria Grazia ^e   Missale, Cristina ^a   Spano, PierFranco ^a,f   Bellucci, Arianna ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f IRCCS San Camillo Hospital   (Italy)

Author keywords

Dopamine release; Parkinson's disease; Synapsin III; Synaptic vesicles; synuclein

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; PHOSPHOPROTEIN; SYNAPSIN III; UNCLASSIFIED DRUG; COCAINE; DOPAMINE TRANSPORTER; MUTANT PROTEIN; PROTEIN AGGREGATE; PROTEIN BINDING; SYNAPSIN;

ANIMAL CELL; ARTICLE; CAUDATE NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PUTAMEN; SYNAPSE; SYNAPSE VESICLE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL FRACTIONATION; CORPUS STRIATUM; DEFICIENCY; GENE SILENCING; HUMAN; METABOLISM; MOTOR ACTIVITY; PARKINSON DISEASE; SYNAPTOSOME; TRANSGENIC MOUSE; ULTRASTRUCTURE;

MUS;

ALPHA-SYNUCLEIN; ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINERGIC NEURONS; GENE SILENCING; HUMANS; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MOTOR ACTIVITY; MUTANT PROTEINS; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; PROTEIN AGGREGATES; PROTEIN BINDING; PUTAMEN; SUBCELLULAR FRACTIONS; SYNAPSES; SYNAPSINS; SYNAPTIC VESICLES;

EID: 84935491802     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.157867     Document Type: Article

References (38)

1. Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M., Armanini, M., Ryan, A. et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.
2. Anichtchik, O., Calo, L. and Spillantini, M. G. (2013). Synaptic dysfunction in synucleinopathies. CNS Neurol. Disord. Drug Targets 12, 1094-1100.
3. Bellani, S., Mescola, A., Ronzitti, G., Tsushima, H., Tilve, S., Canale, C., Valtorta, F. and Chieregatti, E. (2014). GRP78 clustering at the cell surface of neurons transduces the action of exogenous alpha-synuclein. Cell Death Differ. 21, 1971-1983.
4. Bellucci, A., Collo, G., Sarnico, I., Battistin, L., Missale, C. and Spano, P. (2008). Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. J. Neurochem. 106, 560-577.
5. Bellucci, A., Navarria, L., Falarti, E., Zaltieri, M., Bono, F., Collo, G., Grazia, M., Missale, C. and Spano, P. (2011a). Redistribution of DAT/alpha-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease. PLoS ONE 6, e27959.
6. Bellucci, A., Navarria, L., Zaltieri, M., Falarti, E., Bodei, S., Sigala, S., Battistin, L., Spillantini, M., Missale, C. and Spano, P. (2011b). Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease. J. Neurochem. 116, 588-605.
7. Bellucci, A., Zaltieri, M., Navarria, L., Grigoletto, J., Missale, C. and Spano, P. (2012). From alpha-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease. Brain Res. 1476, 183-202.
8. Bogen, I. L., Boulland, J.-L., Mariussen, E.,Wright, M. S., Fonnum, F., Kao, H.-T. and Walaas, S. I. (2006). Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters. J. Neurochem. 96, 1458-1466.
9. Boyer, F. and Dreyer, J.-L. (2007). Alpha-synuclein in the nucleus accumbens induces changes in cocaine behaviour in rats. Eur. J. Neurosci. 26, 2764-2776.
10. Braak, H., Sastre, M. and Del Tredici, K. (2007). Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol. 114, 231-241.
11. Brenz Verca, M. S., Bahi, A., Boyer, F., Wagner, G. C. and Dreyer, J.-L. (2003). Distribution of alpha- and gamma-synucleins in the adult rat brain and their modification by high-dose cocaine treatment. Eur. J. Neurosci. 18, 1923-1938.
12. Burre, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R. and Sudhof, T. C. (2010). Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663-1667.
13. Busch, D. J., Oliphint, P. A.,Walsh, R. B., Banks, S. M. L.,Woods,W. S., George, J. M. and Morgan, J. R. (2014). Acute increase of alpha-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation. Mol. Biol. Cell 25, 3926-3941.
14. Cesca, F., Baldelli, P., Valtorta, F. and Benfenati, F. (2010). The synapsins: key actors of synapse function and plasticity. Prog. Neurobiol. 91, 313-348.
15. Chadchankar, H. and Yavich, L. (2011). Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein. Brain Res. 1423, 67-76.
16. Chadchankar, H., Ihalainen, J., Tanila, H. and Yavich, L. (2011). Decreased reuptake of dopamine in the dorsal striatum in the absence of alpha-synuclein. Brain Res. 1382, 37-44.
17. Chadchankar, H., Ihalainen, J., Tanila, H. and Yavich, L. (2012). Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an alpha-synuclein-dependent mechanism. J. Pharmacol. Exp. Ther. 341, 484-492.
18. Crowther, R. A., Jakes, R., Spillantini, M. G. and Goedert, M. (1998). Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett. 436, 309-312.
19. Feng, J., Chi, P., Blanpied, T. A., Xu, Y., Magarinos, A. M., Ferreira, A., Takahashi, R. H., Kao, H. T., McEwen, B. S., Ryan, T. A. et al. (2002). Regulation of neurotransmitter release by synapsin III. J. Neurosci. 22, 4372-4380.
20. Games, D., Seubert, P., Rockenstein, E., Patrick, C., Trejo, M., Ubhi, K., Ettle, B., Ghassemiam, M., Barbour, R., Schenk, D. et al. (2013). Axonopathy in an alpha-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated alpha-synuclein. Am. J. Pathol. 182, 940-953.
21. Garcia-Reitbock, P., Anichtchik, O., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B., Della Corte, L., Spano, P., Tofaris, G. K. et al. (2010). SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 133, 2032-2044.
22. Garcia-Reitboeck, P., Anichtchik, O., Dalley, J. W., Ninkina, N., Tofaris, G. K., Buchman, V. L. and Spillantini, M. G. (2013). Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra. Exp. Neurol. 248, 541-545.
23. Gaugler, M. N., Genc, O., Bobela,W., Mohanna, S., Ardah, M. T., El-Agnaf,O. M., Cantoni, M., Bensadoun, J.-C., Schneggenburger, R., Knott, G. W. et al. (2012). Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropathol. 123, 653-669.
24. Kile, B. M., Guillot, T. S., Venton, B. J., Wetsel, W. C., Augustine, G. J. and Wightman, R. M. (2010). Synapsins differentially control dopamine and serotonin release. J. Neurosci. 30, 9762-9770.
25. Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V., Chaudhry, F. A., Edwards, R. H. et al. (2006). Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915-11922.
26. Lundblad, M., Decressac, M., Mattsson, B. and Bjorklund, A. (2012). Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons. Proc. Natl. Acad. Sci. USA 109, 3213-3219.
27. Maiya, R., Ponomarev, I., Linse, K. D., Harris, R. A. and Mayfield, R. D. (2007). Defining the dopamine transporter proteome by convergent biochemical and in silico analyses. Genes Brain Behav. 6, 97-106.
28. Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A. and Edwards, R. H. (2010). Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79.
29. Porton, B., Wetsel, W. C. and Kao, H.-T. (2011). Synapsin III: role in neuronal plasticity and disease. Semin. Cell Dev. Biol. 22, 416-424.
30. Prasad, K., Beach, T. G., Hedreen, J. and Richfield, E. K. (2012). Critical role of truncated alpha-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease. Brain Pathol. 22, 811-825.
31. Qin, Y., Ouyang, Q., Pablo, J. and Mash, D. C. (2005). Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport 16, 1489-1493.
32. Specht, C. G. and Schoepfer, R. (2001). Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC. Neurosci. 2, 11.
33. Spinelli, K. J., Taylor, J. K., Osterberg, V. R., Churchill, M. J., Pollock, E., Moore, C., Meshul, C. K. and Unni, V. K. (2014). Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. J. Neurosci. 34, 2037-2050.
34. Tao-Cheng, J.-H. (2006). Activity-related redistribution of presynaptic proteins at the active zone. Neuroscience 141, 1217-1224.
35. Tofaris, G. K., Reitböck, P. G., Humby, T., Lambourne, S. L., O'Connell, M., Ghetti, B., Gossage, H., Emson, P. C., Wilkinson, L. S., Goedert, M. et al. (2006). Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J. Neurosci. 26, 3942-3950.
36. Venton, B. J., Seipel, A. T., Phillips, P. E.,Wetsel,W. C., Gitler, D., Greengard, P., Augustine, G. J. and Wightman, R. M. (2006). Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J. Neurosci. 26, 3206-3209.
37. Volz, T. J., Farnsworth, S. J., Hanson, G. R. and Fleckenstein, A. E. (2008). Methylphenidate-induced alterations in synaptic vesicle trafficking and activity. Ann. N. Y. Acad. Sci. 1139, 285-290.
38. Yavich, L., Tanila, H., Vepsäläinen, S. and Jäkälä, P. (2004). Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci. 24, 11165-11170.